Supreme Court of the United States
Skip Navigation LinksHome | Search Results

        

Docket for 10-844
No. 10-844
Title:
Caraco Pharmaceutical Laboratories, Ltd., et al., Petitioners
v.
Novo Nordisk A/S, et al.
Docketed:December 28, 2010
Linked with 10A380
Lower Ct:United States Court of Appeals for the Federal Circuit
  Case Nos.:(2010-1001)
  Decision Date:April 14, 2010
  Rehearing Denied:July 29, 2010
Questions Presented

~~~Date~~~ ~~~~~~~Proceedings  and  Orders~~~~~~~~~~~~~~~~~~~~~
Oct 15 2010 Application (10A380) to extend the time to file a petition for a writ of certiorari from October 27, 2010 to December 26, 2010, submitted to The Chief Justice.
Oct 18 2010 Application (10A380) granted by The Chief Justice extending the time to file until December 23, 2010.
Dec 23 2010 Petition for a writ of certiorari filed. (Response due January 27, 2011)
Jan 10 2011 Order extending time to file response to petition to and including February 25, 2011.
Jan 27 2011 Brief amicus curiae of Teva Pharmaceuticals USA, Inc. filed.
Jan 27 2011 Brief amicus curiae of Generic Pharmaceutical Association filed.
Jan 27 2011 Brief amici curiae of Consumer Federation of America and U.S. PIRG filed.
Jan 27 2011 Brief amicus curiae of Mylan Pharmaceuticals, Inc. filed.
Jan 27 2011 Brief amicus curiae of Apotex, Inc. filed.
Feb 25 2011 Brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. in opposition filed.
Mar 7 2011 Reply of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed.
Mar 9 2011 DISTRIBUTED for Conference of March 25, 2011.
Mar 28 2011 The Acting Solicitor General is invited to file a brief in this case expressing the views of the United States.
May 26 2011 Brief amicus curiae of United States filed.
Jun 3 2011 Supplemental brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. filed.
Jun 7 2011 DISTRIBUTED for Conference of June 23, 2011.
Jun 7 2011 Supplemental brief of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed. (Distributed)
Jun 27 2011 Petition GRANTED.
Jul 13 2011 The time to file the joint appendix and petitioners' brief on the merits is extended to and including August 29, 2011.
Jul 13 2011 The time to file respondents' brief on the merits is extended to and including October 17, 2011.
Aug 16 2011 Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents.
Aug 29 2011 Joint appendix filed (two volumes). (Statement of costs filed)
Aug 29 2011 Brief of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed.
Sep 6 2011 Brief amicus curiae of United States filed.
Sep 6 2011 Brief amicus curiae of Generic Pharmaceutical Association filed.
Sep 6 2011 Brief amicus curiae of Rep. Henry A. Waxman filed.
Sep 6 2011 Brief amici curiae of AARP and U.S. PIRG filed.
Sep 6 2011 Brief amicus curiae of Mylan Pharmaceuticals, Inc. filed.
Sep 12 2011 SET FOR ARGUMENT ON Monday, December 5, 2011.
Sep 19 2011 CIRCULATED
Sep 26 2011 Record received from U.S.C.A. for Federal Circuit. (1 box)
Sep 27 2011 Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
Oct 17 2011 Brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. filed. (Distributed)
Oct 24 2011 Brief amici curiae of Allergan, Inc., et al. filed. (Distributed)
Oct 24 2011 Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. (Distributed)
Oct 24 2011 Brief amicus curiae of Washington Legal Foundation filed. (Distributed)
Nov 7 2011 Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED.
Nov 16 2011 Reply of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed. (Distributed)
Dec 5 2011 Argued. For petitioners: James F. Hurst, Chicago, Ill.; and Benjamin J. Horwich, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondents: Mark A. Perry, Washington, D. C.
Dec 13 2011 Record from U.S.D.C. for Eastern District of Michigan is electronic.
Apr 17 2012 Judgment REVERSED and case REMANDED. Kagan, J., delivered the opinion for a unanimous Court. Sotomayor, J., filed a concurring opinion.
May 21 2012 JUDGMENT ISSUED.
May 31 2012 Record returned to U.S.C.A. for Fedral Circuit.



~~Name~~~~~~~~~~~~~~~~~~~~~    ~~~~~~~Address~~~~~~~~~~~~~~~~~~   ~~Phone~~~
Attorneys for Petitioners:
Steffen N. Johnson Winston & Strawn LLP(202) 282-5000
    Counsel of Record1700 K Street, N.W.
Washington, DC  20006
sjohnson@winston.com
Party name: Caraco Pharmaceutical Laboratories, Ltd., et al.
Attorneys for Respondents:
Mark A. Perry Gibson Dunn & Crutcher LLP(202) 955-8500
    Counsel of Record1050 Connecticut Ave., N.W.
Washington, DC  20036
mperry@gibsondunn.com
Party name: Novo Nordisk A/S, and Novo Nordisk Inc.
Other:
Carlos T. Angulo Zuckerman Spaeder LLP(202) 778-1800
1800 M St., N.W., Suite 100
Washington, DC  20038
cangulo@zuckerman.com
Party name: Rep. Henry A. Waxman
 
Dan L. Bagatell Perkins Coie LLP(602) 351-8000
2901 N. Central Avenue
Suite 2000
Phoenix, AZ  85012
DBagatell@perkinscoie.com
Party name: Mylan Pharmaceuticals, Inc.
 
David A. Balto Law Offices of David A. Balto(202)-789-5424
1325 G Street, NW, Suite 500
suite 850
Washington, DC  20005
david.balto@yahoo.com
Party name: Consumer Federation of America and U.S, PIRG
 
Roy T. Englert Jr. Robbins, Russell, Englert, Orseck, Untereiner & Sauber LLP(202) 775-4500
1801 K Street, N.W., Suite 411
Washington, DC  20006
renglert@robbinsrussell.com
Party name: Generic Pharmaceutical Association
 
Benjamin Horwich Assistant to the Solicitor General
Department of Justice
Washington, DC  20530
Party name: Caraco Pharmaceutical Laboratories, Ltd., et al. v. Novo Nordisk A/S, et al.
 
Robert A. Long Jr. Covington & Burling LLP(202) 662-6000
1201 Pennsylvania Avenue, N.W.
Washington, DC  20004
rlong@cov.com
Party name: Pharmaceutical Research and Manufacturers of America
 
Richard A. Samp Washington Legal Foundation(202) 588-0302
2009 Massachusetts Ave., NW
Washington, DC  20036
rsamp@wlf.org
Party name: Washington Legal Foundation
 
Michael D. Shumsky Kirkland & Ellis LLP(202) 879-5000
655 Fifteenth Street, N. W.
Washington, DC  20005
mshumsky@kirkland.com
Party name: Teva Pharmaceuticals USA, Inc.
 
Jonathan Singer Fish & Richardson P.C.(612) 335-5070
3200 RBC Plaza
60 South Sixth Street
Minneapolis, MN  55402
singer@fr.com
Party name: Allergan, Inc., et al.
 
Shashank S. Upadhye Vice President(416) 401-7701
Global Head of Intellectual Property Apotex, Inc.
150 Signet Drive
Toronto, ON, XX  Canada M19L 1T9
supadhye@apotex.com
Party name: Apotex, Inc.
 
Donald B. Verrilli Jr. Solicitor General(202) 514-2217
United States Department of Justice
950 Pennsylvania Avenue, N.W.
Washington, DC  20530-0001
SupremeCtBriefs@USDOJ.gov
Party name: United States
November 24, 2014 | Version 2014.1